Insight: Crunching the Numbers to Boost Odds Against Cancer

In just the last 2 years there have been updates in classification, risk assessment, and response criteria in myelodysplastic syndromes, but additional efforts are needed to improve these, and there remains a need for better therapies.

In part 2 of this 2-part podcast, a panel of experts discusses challenges with biosimilar uptake, interchangeability studies, patient and provider education.

The treatment combined adoptive T-cell therapy with a personalized cancer vaccine and was found to be safe in a small cohort of 17 patients.

Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.

A rapid growth in vaping and e-cigarettes use among teens is associated with increased risk of asthma, according to a new study.

Elevated serum endotrophin levels, but not urinary endotrophin levels, predict increased risk of kidney complications and mortality in type 1 diabetes.